Listeria monocytogenes: a promising vector for tumor immunotherapy
Cancer receives enduring international attention due to its extremely high morbidity and mortality. Immunotherapy, which is generally expected to overcome the limits of traditional treatments, serves as a promising direction for patients with recurrent or metastatic malignancies. Bacteria-based vect...
Auteurs principaux: | , , , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Frontiers Media S.A.
2023-10-01
|
Collection: | Frontiers in Immunology |
Sujets: | |
Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1278011/full |